CMBI, TML and Human Genetics organized a successful summerschool on 'Integrative X-omics Analyses Empowering Personalized Healthcare'.The course coordinators professor Alain van Gool and professor Peter-Bram ‘t Hoen are looking back at an exciting week, in which 20 participants from all over Europe convened for a week full of lectures, practicals, and labtours. The week started with an introduction into biomarkers for personalized healthcare by Alain van Gool (TML). Marcel Nelen (Human Genetics) introduced them into novel genomics technologies, and Hans Wessels and Jolein Gloerich (TML) did the same for novel proteomics technologies. Peter-Bram ‘t Hoen presented a range of X-omics data integration strategies. Other topics like metabolomics, methylation and network-based data integration were covered by external speakers from the Netherlands X-omics Initiative.
Throughout the week, the participants worked on an assignment for which they needed to design a X-omics study, and define a data analysis and management plan. The participants worked in multidisciplinary teams of four. Their different scientific backgrounds helped to address this assignment from different angles. On Friday, the participants presented their exciting studies covering a range of different topics: from the study of the influence of microbiome on constipation in Parkinson's disease, to the identification of early marker signals for infection in rheumatoid arthritis patients after treatment with tocublizimab, risk assessment in prostate cancer based on combined imaging and -omics profiling, the molecular mechanisms of non-alcoholic fatty liver disease, and the early detection of cerebral course of disease in X-linked adrenoleukodystrophy.
The organizers are looking forward to a next edition.
More information about the program can be found here.
Related news items
Biomarkers found in COVID-19 patients support bradykinin hypothesis29 May 2020
A study into inflammatory substances in the blood of COVID-19 patients supports the hypothesis that kinins could play a role in the respiratory problems experienced by critically ill COVID-19 patients in IC. This discovery, published at MedRxiv, could lead to the development of new treatments.read more
Introducing OnePlanet Research Center webinar 5 June, 16:00 hrs.29 May 2020
OnePlanet Research Center develops digital technologies to create a society in which everyone can live a healthy life and has access to healthy and sustainable food. Radboudumc and Radboud University are amongst the founding partners. Find out what OnePlanet can do for you in this online session.read more
Terrestrial bacteria can grow on nutrients from space26 May 2020
Researchers from the Radboudumc describe in an article in Astrobiology that bacteria can survive on an 'extraterrestrial diet', which affected their pathogenic potential.read more
First clinical trial with genetically modified malaria vaccine completed22 May 2020
In an innovative study, Radboudumc and LUMC jointly tested a candidate vaccine based on a genetically weakened malaria parasite. The results of this clinical trial, published in Science Translational Medicine, show that the vaccine is safe and elicits a defense response against a malaria infection.read more